Quarterly report pursuant to Section 13 or 15(d)
Nature of the Business - Narrative (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 31, 2021 |
|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||||||
PCR testing, amount recorded, COVID-19 | $ 6,100,000 | $ 0 | $ 6,061,000 | |||
PCR testing, write-offs, COVID-19 | 5,300,000 | |||||
PCR testing, general and administrative expenses, COVID-19 | $ 0 | $ 0 | $ 800,000 | 0 | ||
COVID-19, deferred social security payroll tax | $ 3,000,000 | $ 3,000,000 | $ 3,000,000 |
X | ||||||||||
- Definition Polymerase Chain Reaction Testing, Exit Costs, COVID-19 No definition available.
|
X | ||||||||||
- Definition Polymerase Chain Reaction Testing, General and Administrative Expenses, COVID-19 No definition available.
|
X | ||||||||||
- Definition Polymerase Chain Reaction Testing, Write-Offs, COVID-19 No definition available.
|
X | ||||||||||
- Definition Social Security Tax, Employer, Deferral, CARES Act No definition available.
|
X | ||||||||||
- References No definition available.
|